Static lung compliance (Cst) and diffusion lung capacity (DLCO) as markers of lung function impairment in sarcoid patients with normal lung volumes Source: Eur Respir J 2003; 22: Suppl. 45, 278s Year: 2003
Static lung compliance and DLCO often demonstrate parenchymal involvement in sarcoidosis despite a normal total lung capacity Source: Annual Congress 2009 - Sarcoidosis in review Year: 2009
No effect of baseline diffusing capacity of lung for carbon monoxide on benefit of nintedanib Source: International Congress 2016 – IPF treatment II Year: 2016
Lung volumes, diffusing capacity and static lung compliance in patients with UIP pattern of IPF Source: Eur Respir J 2002; 20: Suppl. 38, 62s Year: 2002
Correlation between spirometric indices (FEV1, FVC) and lung diffusion values (DLCO) in subjects with varying severity of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007
Forced vital capacity, total lung capacity and diffusion capacity in idiopathic pulmonary fibrosis Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018
Lung Clearance Index (LCI) and diffusion capacity of the lung (DLCO) in children with rheumatic disease Source: Virtual Congress 2020 – Unusual tools for evaluating obstructive diseases Year: 2020
Quality of spirometry and diffusion of the lung (DLCO) data in patients with systemic sclerosis. Source: International Congress 2019 – Insights into physiological diagnostic services Year: 2019
The role of spirometry and ?arbon monoxide diffusing capacity (DLCO) in the diagnosis of pulmonary function in patients after COVID-19 pneumonia Source: Virtual Congress 2021 – Pulmonary rehabilitation in the COVID-19 era Year: 2021
Ventilation heterogeneity in COPD and healthy smokers relates to diffusion capacity, resistance and reactance Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015
Six minute walk distance (6MWD) and pulmonary diffusing capacity (DLCO) in patients with COPD Source: International Congress 2015 – COPD: notable points Year: 2015
Total lung capacity (TLC) or vital capacity (VC) - which is more reduced in interstitial lung disease (ILD) patients? Source: Eur Respir J 2001; 18: Suppl. 33, 150s Year: 2001
Correlation between exercise capacity with FVC%, FEV1% and RV% in patients with airways diseases and severe and very severe lung function obstruction Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications Year: 2016
Diffusion capacity of lung (DLCO ) at rest as a predictor for exercise induced arterial oxygen desaturation in COPD patients Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases Year: 2009
Does the decrease in KCO go typically with DLCO decrease in obstructive pulmonary diseases? The relationship with DLCO, KCO, VA and VA/TLC in patients with COPD> Source: International Congress 2018 – Functional assessment of COPD Year: 2018
Elevation of diffusing lung capacity (TLCO) in asthmatic children as a result of ventilation/perfusion disorder Source: Eur Respir J 2003; 22: Suppl. 45, 495s Year: 2003
Modeling of oxygen uptake kinetics during exercise testing in patients with chronic obstructive pulmonary diseases (COPD) Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease Year: 2016
Lung diffusion measurement: effects of alveolar volume changes on diffusing capacity and implications in restrictive lung disease Source: Annual Congress 2004 - PG13 - Lung diffusion measurements in diseases Year: 2004
Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III Source: Eur Respir J 2006; 28: 939-944 Year: 2006
Lung function and exercise capacity in COPD phenotypes with and without emphysema Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020